Clinical and safety impact of an inpatient Pharmacist-Directed anticoagulation service

Journal of Hospital Medicine

Volumn 6, Issue 6, 2011, Pages 322-328

  Schillig, Jessica ^a   Kaatz, Scott ^a   Hudson, Michael ^a   Krol, Gregory D ^a   Szandzik, Edward G ^a   Kalus, James S ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BIOMETRY; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CARDIOEMBOLIC STROKE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLUSTER ANALYSIS; COMPARTMENT SYNDROME; CONTROLLED STUDY; CORONARY CARE UNIT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEART FAILURE; HEMOPERICARDIUM; HEMOPERITONEUM; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL SERVICE; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAARTICULAR BLEEDING; INTRAMUSCULAR BLEEDING; INTRAOCULAR HEMORRHAGE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PHARMACIST DERIVED ANTICOAGULATION SERVICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROPERITONEAL HEMORRHAGE; SPINAL CORD HEMORRHAGE; TEACHING HOSPITAL; THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; CLUSTER ANALYSIS; FEMALE; HOSPITALS, TEACHING; HOSPITALS, URBAN; HUMANS; INPATIENTS; LEADERSHIP; MALE; MEDICATION ERRORS; MIDDLE AGED; PATIENT SAFETY; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE;

EID: 80051560851     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.910     Document Type: Article

References (10)

1. U.S. Pharmacopeia. USP Patient Safety CapsLink: January 2008. Available at: Accessed March 19, 2010.
2. Ansel J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest. 2008; 133: 160S-198S.
3. The Joint Commission. 2009 National Patient Safety Goals. Available at: Accessed May 6, 2010.
4. Dager WE, Branch JM, King JH, et al. Optimization of inpatient warfarin therapy: impact of a daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother. 2000; 34: 567-572.
5. Rivey MP, Wood RD, Allington DR, et al. Pharmacy-managed protocol for warfarin use in orthopedic surgery patients. Am J Health-Syst Pharm. 1995; 52: 1310-1316.
6. Boddy C. Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci. 2001; 23: 31-35.
7. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm. 1992; 49: 387-394.
8. To EK, Pearson GJ. Implementation and evaluation of a pharmacist-assisted warfarin dosing program. Can J Hosp Pharm. 1997; 50: 169-175.
9. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemostasis. 2005; 3: 692-694.
10. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360: 1418-1428.